Interferon-gamma Therapy Activates Human Monocytes for Enhanced Phagocytosis ofMycobacterium aviumComplex in HIV-Infected Individuals
Authors:
- Katherine KedzierskaKKKatherine Kedzierska
- Geza PaukovicsGPGeza Paukovics
- Amanda HandleyAHAmanda Handley
- Marilyn HewishMHMarilyn Hewish
- Jane HockingJHJane Hocking
- Paul U. CameronPCPaul U. Cameron
- Suzanne M. CroweSCSuzanne M. Crowe
- 1 April 2004
- journal article
- research article
- Published by Taylor & Francis in HIV Research & Clinical Practice
- Vol. 5 (2) , 80-85
Abstract
Defective immunological function of cells of the macrophage lineage contributes to the pathogenesis of HIV-1 infection. Because monocyte/macrophage function is enhanced by cytokines such as interferon-gamma (IFN-γ), the use of this immunomodulator is of potential clinical interest as adjunctive immunotherapy in immunosuppressed individuals. In this study, we show that adjunctive IFN-γ treatment in an HIV-infected individual with Mycobacterium avium complex (MAC) infection increased phagocytosis of MAC by blood monocytes when compared to cells from an HIV-infected patient who was receiving standard chemotherapy alone. Enhanced phagocytic efficiency resulting from IFN-γ therapy was associated with increased surface expression of MHC II (HLA-DR), a phagocytic receptor (CD16), and the activation marker (CD69), although the levels of activation markers were dissimilar at baseline in the two participants. These results imply that IFN-γ may be useful in restoring antimycobacterial function in immunosuppressed patients.Keywords
This publication has 15 references indexed in Scilit:
- Granulocyte‐Macrophage Colony‐Stimulating Factor Augments Phagocytosis ofMycobacterium aviumComplex by Human Immunodeficiency Virus Type 1–Infected Monocytes/Macrophages In Vitro and In VivoThe Journal of Infectious Diseases, 2000
- A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial InfectionNew England Journal of Medicine, 1996
- Quantifying phagocytosis of Mycobacterium avium complex by human monocytes in whole bloodImmunology & Cell Biology, 1996
- Treatment of Refractory Disseminated Nontuberculous Mycobacterial Infection With Interferon Gamma: A Preliminary ReportNew England Journal of Medicine, 1994
- Immune Response in Mice that Lack the Interferon-γ ReceptorScience, 1993
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993
- Interferon- Treatment for Mycobacterium avium-intracellulare Complex Bacillemia in Patients with AIDSThe Journal of Infectious Diseases, 1992
- Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediatesCellular Immunology, 1991
- Antagonistic and additive effects of IL-4 and lnterferon-γ on human monocytes and macrophages: Effects on Fc receptors, HLA-D antigens, and superoxide productionCellular Immunology, 1990
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.Journal of Experimental Medicine, 1983